Researchers report a possible link between preservatives and microbial changes that may put the ocular surface at greater risk for inflammation.
Advertisement
Explore TEPEZZA® (teprotumumab-trbw) now for your patients with this serious, progressive disease.
TEPEZZA is a trademark owned by or licensed to Horizon.© 2022 Horizon Therapeutics plc P-TEP-US-00805 12/22